Literature DB >> 9891777

Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

J S Bonifacino1, A M Weissman.   

Abstract

The modification of proteins by chains of ubiquitin has long been known to mediate targeting of cytosolic and nuclear proteins for degradation by proteasomes. In this article, we discuss recent developments that reveal the involvement of ubiquitin in the degradation of proteins retained within the endoplasmic reticulum (ER) and in the internalization of plasma membrane proteins. Both luminal and transmembrane proteins retained in the ER are now known to be retrotranslocated into the cytosol in a process that involves ER chaperones and components of the protein import machinery. Once exposed to the cytosolic milieu, retro-translocated proteins are degraded by the proteasome, in most cases following polyubiquitination. There is growing evidence that both the ubiquitin-conjugating machinery and proteasomes may be associated with the cytosolic face of the ER membrane and that they could be functionally coupled to the process of retrotranslocation. The ubiquitination of plasma membrane proteins, on the other hand, mediates internalization of the proteins, which in most cases is followed by lysosomal/vacuolar degradation. There is, however, a well-documented case of a plasma membrane protein (the c-Met receptor) for which ubiquitination results in proteasomal degradation. These recent findings imply that ubiquitin plays more diverse roles in the regulation of the fate of cellular proteins than originally anticipated.

Mesh:

Substances:

Year:  1998        PMID: 9891777      PMCID: PMC4781171          DOI: 10.1146/annurev.cellbio.14.1.19

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  168 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Identification of discrete classes of endosome-derived small vesicles as a major cellular pool for recycling membrane proteins.

Authors:  S N Lim; F Bonzelius; S H Low; H Wille; T Weimbs; G A Herman
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  Ligand binding directly stimulates ubiquitination of the inositol 1, 4,5-trisphosphate receptor.

Authors:  C C Zhu; R J Wojcikiewicz
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

4.  Asg7p-Ste3p inhibition of pheromone signaling: regulation of the zygotic transition to vegetative growth.

Authors:  A F Roth; B Nelson; C Boone; N G Davis
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.

Authors:  J Ma; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

7.  Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein.

Authors:  Edda Fiebiger; Craig Story; Hidde L Ploegh; Domenico Tortorella
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

8.  Role of the ubiquitin-selective CDC48(UFD1/NPL4 )chaperone (segregase) in ERAD of OLE1 and other substrates.

Authors:  Sigurd Braun; Kai Matuschewski; Michael Rape; Sven Thoms; Stefan Jentsch
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

9.  Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.

Authors:  Y Yedidia; L Horonchik; S Tzaban; A Yanai; A Taraboulos
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

10.  The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum.

Authors:  K Yamamoto; R Fujii; Y Toyofuku; T Saito; H Koseki; V W Hsu; T Aoe
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.